Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

Amid a deluge of cuts to federal spending, the Trump administration has canceled three grants totaling $85.6 million to Santa ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

The head of the World Health Organization on Monday urged countries to adopt this week the Pandemic Agreement, aimed at preventing a repeat of the COVID-19 crisis.

Slovakia's COVID-19 vaccine sceptic prime minister said on Monday that his country would challenge the adoption of a ...

Novavax Inc. jumped after US regulators fully approved its Covid vaccine, easing investors’ concerns after the clearance was ...

Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...

In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with ...

Brazil's government is not considering providing specific aid for Azul as the airline faces financial hurdles, but money from ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Health agencies working under Robert F. Kennedy Jr. are making changes to the nation's decades-old system for approving and ...

Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.